Home › Kanser sa Thyroid
Pag-aaral pangklinika para sa Kanser sa Thyroid na nagre-recruit sa U.S.
48 pag-aaral para sa Kanser sa Thyroid ang nagre-recruit ng mga kalahok sa mga site sa buong Estados Unidos.
Mga lungsod na may pinakamaraming pag-aaral
- Houston, TX10 pag-aaral
- New York City, NY8 pag-aaral
- Washington, DC8 pag-aaral
- Boston, MA7 pag-aaral
- Los Angeles, CA5 pag-aaral
- San Francisco, CA4 pag-aaral
- Philadelphia, PA4 pag-aaral
- Durham, NC4 pag-aaral
- Nashville, TN4 pag-aaral
- Memphis, TN3 pag-aaral
- Baldwin Park, CA3 pag-aaral
- St. Louis, MO3 pag-aaral
- San Antonio, TX3 pag-aaral
Ayos sa estado
- Arizona3 pag-aaral
- California13 pag-aaral
- Colorado5 pag-aaral
- District of Columbia3 pag-aaral
- Florida7 pag-aaral
- Illinois3 pag-aaral
- Maryland7 pag-aaral
- Massachusetts8 pag-aaral
- Michigan3 pag-aaral
- Minnesota5 pag-aaral
- Missouri4 pag-aaral
- New York9 pag-aaral
- North Carolina5 pag-aaral
- Ohio5 pag-aaral
- Pennsylvania5 pag-aaral
- Tennessee7 pag-aaral
- Texas12 pag-aaral
- Virginia3 pag-aaral
Mga pag-aaral na kamakailan lamang in-update
Opisyal na teksto ng pag-aaral (English)
The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer
Nagre-recruitPhase 2
Edad 18 hanggang 98 · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT04927416DICER1-related Pleuropulmonary Blastoma Cancer Predisposition Syndrome: A Natural History Study
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
1 Month – 99 Years · Lahat ng kasarian · Na-update Nob 12, 2026 · NCT01247597An Investigational Scan (hpMRI) for Monitoring Treatment Response in Patients With Thyroid Cancer and Other Malignancies of the Head and Neck Undergoing Radiation Therapy and/or Systemic Therapy
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 10, 2026 · NCT04589624Studies on Tumors of the Thyroid
Nagre-recruitObservasyonal na pag-aaral
6 Months – 98 Years · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT00001160Nanosecond Pulsed Field Ablation in the Management of T1N0M0 Papillary Thyroid Carcinoma
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 9, 2026 · NCT07218315Zanzalintinib for the Treatment of Advanced Thyroid Cancer Before Surgery
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT06959511Evaluation of DNA Methylation Signatures for the Diagnosis and Management of Thyroid Nodules
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT05229341Genetic Analysis of Pheochromocytomas, Paragangliomas and Associated Conditions
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Lahat ng edad · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT03160274Prospective Comprehensive Molecular Analysis of Endocrine Neoplasms
Nagre-recruitObservasyonal na pag-aaral
Edad 4 pataas · Lahat ng kasarian · Na-update Nob 5, 2026 · NCT01005654Active Surveillance of Papillary Thyroid Microcarcinoma
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT02609685cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
Edad 40 pataas · Lahat ng kasarian · Na-update Nob 4, 2026 · NCT05366881Artificial Tears to Prevent Nasolacrimal Duct Obstruction in Patients Treated With Radioactive Iodine for Thyroid Cancer
Nagre-recruitPhase 3Malugod na tinatanggap ang malusog na boluntaryo
Edad 18 pataas · Lahat ng kasarian · Na-update Nob 3, 2026 · NCT05999630The Use of 124-I-PET/CT Whole Body and Lesional Dosimetry in Differentiated Thyroid Cancer
Nagre-recruitPhase 2
Edad 18 hanggang 90 · Lahat ng kasarian · Na-update Okt 29, 2026 · NCT03841617International PPB/DICER1 Registry
Nagre-recruitObservasyonal na pag-aaralMalugod na tinatanggap ang malusog na boluntaryo
0 Minutes – 100 Years · Lahat ng kasarian · Na-update Okt 26, 2026 · NCT03382158Larotrectinib to Enhance RAI Avidity in Differentiated Thyroid Cancer
Nagre-recruitPhase 2
Edad 2 hanggang 99 · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT05783323Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT06239194A Study of Avutometinib and Defactinib in People With Thyroid Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 15, 2026 · NCT06007924Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 13, 2026 · NCT05786924XL092 and Cemiplimab in BRAF WT Thyroid Cancer
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 5, 2026 · NCT06902376DESTINY-PANTUMOUR04
Nagre-recruitObservasyonal na pag-aaral
Edad 18 hanggang 130 · Lahat ng kasarian · Na-update Set 25, 2026 · NCT07124000Global Real World Data in Patients With Advanced Thyroid Cancer on Standard of Care and Specialized Interventions- Registry of Oncologic Outcomes With Testing and Treatment.
Nagre-recruitObservasyonal na pag-aaral
Edad 18 pataas · Lahat ng kasarian · Na-update Set 18, 2026 · NCT06507878Lesion Dosimetry With Iodine-124 in Metastatic Thyroid Carcinoma
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 10, 2026 · NCT03647358A Study of Meaning-Centered Therapy for Mexican Adults With Advanced Cancer
Nagre-recruit
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 3, 2026 · NCT07225309Cyclophosphamide and Sirolimus for the Treatment of Metastatic, RAI-refractory, Differentiated Thyroid Cancer
Nagre-recruitPhase 2
Edad 18 pataas · Lahat ng kasarian · Na-update Hul 31, 2026 · NCT03099356Selpercatinib Pre-RAI in Patients With RET Fusion Thyroid Cancer (RAISE)
Nagre-recruitPhase 2
Edad 2 hanggang 25 · Lahat ng kasarian · Na-update Hul 24, 2026 · NCT06458036Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.